Colleen Scotton
Family · New York, NYNPI 1619368040
Payments from drug & device makers
Across 145 payments — averaging $72.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$6K
- AbbVie$2K
- Johnson & Johnson$1K
- Janssen Scientific Affairs, LLC$208
- E.r. Squibb & Sons, L.L.C.$125
- Takeda Pharmaceuticals U.S.A., Inc.$110
- plus $308 from 7 others
What the payments were for
- Speaking & faculty fees$4,35041%
- Travel & lodging$1,55215%
- Food & beverage$4,21840%
- Education$3774%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 29 | $6,383 |
| AbbVie | 72 | $1,939 |
| Johnson & Johnson | 21 | $1,423 |
| Janssen Scientific Affairs, LLC | 4 | $208 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $110 |
| Ipsen Biopharmaceuticals, Inc | 3 | $98 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $61 |
| Veloxis Pharmaceuticals, Inc. | 1 | $37 |
| QOL Medical, LLC | 1 | $33 |
| Pfizer | 1 | $29 |
| Bristol Myers Squibb | 1 | $26 |
| Sanofi | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,497 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 16 | $4,888 |
| Pantoprazole Sodium | 12 | $82 |
Paid to pharmacies, not to this prescriber.
Other family in New York
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Mary Sullivan-WhalenNew York$137K
- Leslie WoronaNew York$77K
- Thomas SaglimbeniNew York$48K
- Kathryn JohnsonNew York$48K
- Derek PinedaNew York$38K
- Rebecca SchoriNew York$32K
- Evangelia NezisNew York$22K
- Colette NelsonNew York$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.